|
sox17 |
4 |
|
cancer mutations |
3 |
|
gain‐of‐function mutations |
3 |
|
induced pluripotency |
3 |
|
variants of uncertain significance |
3 |
|
cellular reprogramming |
2 |
|
enhancer code |
2 |
|
oct4 |
2 |
|
pou |
2 |
|
protein engineering |
2 |
|
reprogramming |
2 |
|
sox2 |
2 |
|
synthetic transcription factors |
2 |
|
alk inhibitors |
1 |
|
animal cell |
1 |
|
animal experiment |
1 |
|
assessment |
1 |
|
autoinhibition |
1 |
|
bioinformatics |
1 |
|
bovine |
1 |
|
breast cancer |
1 |
|
c-terminal transactivation domain |
1 |
|
cancer |
1 |
|
casp7 |
1 |
|
cell fate conversion |
1 |
|
cell penetrating peptide |
1 |
|
chip-seq |
1 |
|
chromatin accessibility |
1 |
|
combinatorial transcription factors |
1 |
|
coop-seq |
1 |
|
cooperativity |
1 |
|
crizotinib |
1 |
|
deep mutational scanning |
1 |
|
deep sequencing |
1 |
|
developmental biology |
1 |
|
developmental potential |
1 |
|
dhx37 |
1 |
|
dimerization |
1 |
|
directed evolution |
1 |
|
disorders of sex development (dsd) |
1 |
|
dna bending |
1 |
|
dna binding |
1 |
|
dna methylation |
1 |
|
dppa2 |
1 |
|
drug design |
1 |
|
dum |
1 |
|
embryonic stem cells |
1 |
|
endocrine therapy |
1 |
|
endoderm |
1 |
|
endoderm differentiation |
1 |
|
engineered transcription factor |
1 |
|
enhancer region |
1 |
|
epiblast stem cells |
1 |
|
esrrb-sox2 |
1 |
|
estrogen receptor |
1 |
|
etv5 |
1 |
|
evolution |
1 |
|
female |
1 |
|
fibroblast |
1 |
|
fluorescent probes |
1 |
|
foxa1 mutations |
1 |
|
free modeling |
1 |
|
gene regulation |
1 |
|
genomics |
1 |
|
germ cell |
1 |
|
green fluorescent protein |
1 |
|
high-mobility group (hmg) |
1 |
|
high-mobility group domain |
1 |
|
hmg domain |
1 |
|
hmg domains |
1 |
|
homeodomain |
1 |
|
human |
1 |
|
human primordial germ cell-like cells |
1 |
|
human-specific |
1 |
|
induced pluripotent stem cells |
1 |
|
ipsc |
1 |
|
ki-1+ anaplastic large cell lymphoma |
1 |
|
lama1 |
1 |
|
lif/stat3 pathway |
1 |
|
lineage specification |
1 |
|
lineage-specific |
1 |
|
lncrna |
1 |
|
long noncoding rna |
1 |
|
microarray |
1 |
|
mitogen-activated protein kinases interacting kinase |
1 |
|
mnk1 and mnk2 |
1 |
|
molecular evolution |
1 |
|
motif |
1 |
|
motifs |
1 |
|
mouse |
1 |
|
myogenesis |
1 |
|
naive pluripotency |
1 |
|
nanog |
1 |
|
network |
1 |
|
neural gene |
1 |
|
neurodegeneration |
1 |
|
neuron-restrictive silencing factor |
1 |
|
non-human primate |
1 |
|
npm1 gene |
1 |
|
nrsf |
1 |
|
oct6 |
1 |
|
paired domain |
1 |
|
paralog mapping |
1 |
|
pax6 |
1 |
|
pax9 |
1 |
|
pioneer tfs |
1 |
|
pioneer transcription factor |
1 |
|
pluripotency |
1 |
|
pluripotency mechanisms |
1 |
|
porcine |
1 |
|
positional interdependence |
1 |
|
pou factors |
1 |
|
pou linker |
1 |
|
primate |
1 |
|
primate-specific |
1 |
|
protein - dna recognition |
1 |
|
protein design |
1 |
|
protein kinase regulation |
1 |
|
protein-dna interaction |
1 |
|
protein-dna recognition |
1 |
|
protein-protein interaction |
1 |
|
re1 |
1 |
|
re1-silencing transcription factor |
1 |
|
regulation |
1 |
|
reprogramming to pluripotency |
1 |
|
reset |
1 |
|
rest |
1 |
|
ribosomopathy |
1 |
|
rna helicase |
1 |
|
rna-seq |
1 |
|
salicylate |
1 |
|
single-molecule studies |
1 |
|
smad-binding element |
1 |
|
smad1 mh1 domain |
1 |
|
small-molecule |
1 |
|
sox |
1 |
|
sox genes |
1 |
|
sox transcription factor |
1 |
|
sox transcription factors |
1 |
|
sox/oct interaction |
1 |
|
sox15 |
1 |
|
sox2/oct4 heterodimer structure |
1 |
|
stat3 protein |
1 |
|
stem cells |
1 |
|
structure prediction |
1 |
|
super-sox |
1 |
|
synthetic biology |
1 |
|
testicular regression syndrome |
1 |
|
tetraploid complementation |
1 |
|
transactivation |
1 |
|
transcription |
1 |
|
transcription factor |
1 |
|
transcription factor binding |
1 |
|
transcription factor engineering |
1 |
|
transcription factors |
1 |
|
transcriptional regulation |
1 |
|
variant data integration |
1 |
|
wnt signaling |
1 |
|
wnt/b-catenin pathway |
1 |
|
β-catenin |
1 |
|
δ-crystallin dc5 enhancer |
1 |
